Oct 21, 2026 07:03AM
Oct 21, 2026 07:00AM
Oct 16, 2026 12:00PM
Oct 16, 2026 12:00PM
Sep 10, 2026 02:12PM
Sep 9, 2026 12:25PM
Sep 9, 2026 11:55AM Four Biotech Stories Heating Up Right Now
Sep 9, 2026 07:07AM
Aug 19, 2026 04:05PM
Aug 19, 2026 04:05PM
Aug 6, 2026 07:00AM
Aug 3, 2026 07:00AM
Aug 3, 2026 07:00AM
Jul 9, 2026 07:02AM Opus Genetics sets September timeline for OPGx-BEST1 trial data
Jul 9, 2026 07:00AM
Jul 6, 2026 12:06PM
Jul 6, 2026 12:05PM
Jul 6, 2026 07:01AM
Jul 6, 2026 07:00AM
Jun 23, 2026 06:40AM
Jun 17, 2026 04:19AM Opus Genetics (IRD) Reiterated at Market Outperform by Citizens after R&D Day
May 12, 2026 07:00AM
May 5, 2026 04:21AM
May 4, 2026 04:30PM
May 4, 2026 04:30PM
May 4, 2026 10:14AM
Apr 10, 2026 06:59AM
Mar 10, 2026 07:00AM Opus Genetics Announces Financial Results for Full Year 2025 and Provides Corporate Update
Feb 25, 2026 06:59AM
Feb 25, 2026 06:59AM
Jan 20, 2026 05:06AM
Jan 8, 2026 07:07AM
Jan 8, 2026 07:00AM
Nov 12, 2025 07:00AM
Nov 6, 2025 07:03AM Opus Genetics advances LCA5 gene therapy toward pivotal trial after FDA meeting
Nov 6, 2025 07:01AM
Nov 6, 2025 07:00AM
Nov 6, 2025 07:00AM
Oct 1, 2025 06:55AM
Sep 30, 2025 07:00AM
Sep 30, 2025 07:00AM
Sep 4, 2025 08:00AM Opus Genetics doses first patient in phase 3 trial for vision solution
Sep 4, 2025 08:00AM
Aug 18, 2025 08:01AM
Aug 18, 2025 08:00AM
Aug 13, 2025 04:30PM
Aug 5, 2025 08:00AM
Jul 23, 2025 08:00AM
Jul 3, 2025 04:30PM Opus Genetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 26, 2025 06:56AM

335,353 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All